Bhojnagarwala, Pratik S.
Bordoloi, Devivasha
Jose, Joshua
Perales-Puchalt, Alfredo
Yan, Jian
Sardesai, Niranjan Y.
Weiner, David B.
Article History
Received: 10 November 2025
Accepted: 9 January 2026
First Online: 14 February 2026
Declarations
:
: APP, JY and NYS are employees of Geneos Therapeutics (APP is currently at JnJ). DBW has received grant funding, participates in industry collaborations, has received speaking honoraria, and has received fees for consulting, including serving on scientific review committees. Remunerations received by DBW include direct payments and equity/options. DBW also discloses the following associations with commercial partners: Geneos (consultant/advisory board), AstraZeneca (advisory board, speaker), Inovio (board of directors, consultant), Sanofi (advisory board), Pfizer (advisory board), and Advaccine (consultant). The other authors declare that they have no competing interests.